Loading stock data…
Revvity, Inc. (RVTY)
$127.08-3.14 (-2.41%)
Market ClosedLast close Sep 8
Revvity, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Revvity, Inc. in the Healthcare sector is trading at $127.08 with a market capitalization of $13.0B. Wall Street consensus targets $125.25 (16 analysts), implying a -1.4% move over the next 12 months. The stock is currently near its 52-week high of $133.00, remaining 24.1% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $711.12M↓ | $772.06M↑ | $698.95M↓ | $720.28M |
| Gross Profit | — | $387.65M↓ | $421.66M↑ | $374.60M↓ | $392.56M |
| Operating Income | — | $75.89M↓ | $111.75M↑ | $81.90M↓ | $89.06M |
| Net Income | — | $40.72M↓ | $98.36M↑ | $46.65M↓ | $53.95M |
Peer Comparison
JNJUNHPFE
Fundamentals
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.04B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
56.44
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.07
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.22%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.59%
Volume
Today's trading volume
1.49M
Recent News
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
Revvity's raised 2026 outlook, Diagnostics growth and stronger cash flow brighten the setup, but premium valuation and software risks call for selectivity.
Revvity (RVTY) Stock Looks Fair On Cash Flow Yet Pricey On Earnings
Revvity has delivered a strong 57.5% return over the past year, while valuation checks send mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock is roughly in line with fair value, and market-based multiples point to a richer price. Revvity’s 57.5% 1 year return sets a high bar for new buyers, who now need the fundamentals to justify a much higher share price base. The key support for the current valuation can come from the company’s ability to convert...
Revvity (RVTY) Margins Story Faces A Valuation Test Following Its Zacks Upgrade
Revvity (RVTY) is back in focus after a recent Zacks upgrade to Rank #2, which reflects improved earnings expectations even as questions remain about growth momentum and rising competitive pressure. Over the past year Revvity’s share price return has been strong, with a 30 day share price return of 12.5%, a 90 day share price return of 25.25% and a year to date share price return of 28.98%, while the 1 year total shareholder return is 44.46%. This suggests that positive momentum has been...
3 Hyped Up Stocks We Find Risky
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
What Makes Revvity (RVTY) a New Buy Stock
Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).